2025 term · Roberts Court · 9-0
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
608 U.S. 580
The record
- Term
- 2025
- Decided
- Issue area
- —
- Vote split
- 9-0
- Winning party
- —
- Decision direction
- —
- Chief Justice
- Roberts Court
- Disposition
- —
- Docket
- 24-889
- U.S. Reports
- 608 U.S. 580
- S. Ct. citation
- —
- LEXIS citation
- —
- Opinion by
- Ketanji Brown Jackson
Holding
Amarin has failed to state a claim for actively inducing infringement of its brand-name drug’s patented uses in violation of 35 U. S. C. §271(b), so its complaint cannot withstand Hikma’s motion to dismiss.
How the bench divided
MMMMMMMMM
M 9 majority
| Justice | Vote |
|---|---|
| Ketanji Brown Jackson | Majority |
| John G. Roberts | Majority |
| Clarence Thomas | Majority |
| Samuel Alito | Majority |
| Sonia Sotomayor | Majority |
| Elena Kagan | Majority |
| Neil Gorsuch | Majority |
| Brett Kavanaugh | Majority |
| Amy Coney Barrett | Majority |
Read the opinion
- supremecourt.govSlip opinionThe opinion as released by the Court, in slip form.
- JustiaFull opinion textThe majority, concurring and dissenting opinions as handed down.
- supremecourt.govDocket 24-889Filings, orders and the procedural history on the Court’s own docket.
- OyezCase pageArgument audio and the vote lineup, when Oyez has published them.